The pharmaceutical industry isn’t working for most people in the US. Over 80 percent of Americans across the political spectrum believe that lowering drug costs should be a “top priority” for lawmakers and believe that prescription drug costs are “unreasonable.” This growing scrutiny presents an opportunity to question the ways that drug corporations run business, as

FOR IMMEDIATE RELEASE: February 21, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org Kathy Mulady, k.mulady@peoplesaction.org   Creation of a Crisis: Why the Pharmaceutical Industry Chooses Profit Over People New issue brief explores how US policy choices have led to high drug prices, low health care investment, misaligned incentives, and escalating CEO pay across the pharmaceutical industry